跳至主要内容
临床试验/NCT01755702
NCT01755702终止2 期

A Study to Assess the Efficacy of Paracetamol Taken in Combination With Caffeine for the Treatment of Episodic Tension Type Headache

GlaxoSmithKline7 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2009年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
66
试验地点
7
主要终点
Time to First Perceptible Headache Relief

研究概览

简要总结

This study will compare a fast-absorbing paracetamol plus caffeine formula with placebo and an over-the-counter dose of paracetamol and ibuprofen to treat episodic tension headache.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of episodic tension-type headache consistent with all of the following:
  • number of days with the condition is historically greater than or equal to two per month
  • onset of condition was greater than or equal to 12 months from Visit 1
  • age of onset was < 50 years
  • severity of headaches is historically at least moderate
  • duration of headaches is historically greater than or equal to four hours, if untreated
  • number of headache episodes was greater than or equal to 4 and less than or equal to 10 during each of the three months immediately prior to Visit 1
  • treatment of headache episodes with OTC analgesics has historically provided pain relief in less than or equal to 2 hours

排除标准

  • Subject has chronic tension type headache, which is defined as headache on more than 15 days per month for 3 months.
  • If a migraine sufferer,subject averages more than one episode per month, is incapable of differentiating between tension-type headaches and migraine headaches, and/or requires regular or prophylactic use of migraine medications

研究组 & 干预措施

Arm 1

Placebo Comparator

Placebo

干预措施: Placebo (Drug)

Arm 2

Active Comparator

paracetamol marketed forumulation

干预措施: Paracetamol marketed formulation (Drug)

Arm 3

Active Comparator

ibuprofen marketed formulation

干预措施: ibuprofen marketed formulation (Drug)

Arm 4

Experimental

experimental paracetamol + caffeine formulation

干预措施: Experimental paracetamol + caffeine formulation (Drug)

结局指标

主要结局

Time to First Perceptible Headache Relief

时间窗: Baseline to 6 hours

Time to first perceptible pain relief, calculated as time when partcipant selected 'a little' pain relief in the electronic pad minus the time of treatment. If this time was not available in the electronic pad then the earliest time corresponding to a pain relief score 1 or greater was recorded as time to 'a little' pain relief.

次要结局

  • Headache Relief Scores(Baseline to 4 hours)
  • Total Pain Relief (TOTPAR)(Baseline to 4 hours)
  • Sum of Pain Intensity Difference (SPID)(Baseline to 4 hours)
  • Sum of TOTPAR and SPID (SPRID)(Baseline to 4 hours)
  • Time to Rescue Medication(Baseline to 6 hours post dose)
  • Number of Participants With Complete Headache Relief(Baseline to 2 hours)
  • Headache Severity(Baseline to 4 hours)
  • Patients Global Assessment in Response to Treatment(Baseline to 8 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验